COHERUS BIOSCIENCES, INC

Lobbying client · California · filed 2025 to 2026

pharmaceutical development

$320,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (51323), not by name.

Firms hired 1

INLET STRATEGIES $320,000 6 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $200,000 4 filings

Issues lobbied 2

Health Issues 6
Medicare/Medicaid 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 6
SENATE 6
White House Office 6
Commerce, Dept of (DOC) 4
Energy, Dept of 2
Health & Human Services, Dept of (HHS) 2

Recent filings 6 total

Q2

INLET STRATEGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

INLET STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 19, 2026

View → Q4

INLET STRATEGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 18, 2026

View → Q3

INLET STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 15, 2025

View → Q2

INLET STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $45,000 income · posted Jul 14, 2025

View → Q1

INLET STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $45,000 income · posted Apr 14, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.